Journal of Blood & Lymph

Ortiz MBA

Publications

• Case Report
  Gemcitabine and Hemolytic Uremic Syndrome: a Case Report
  Author(s): Villalba NL, Merzouki T, González NS, Ortiz MBA, Kechida M, Bailon MM, Zamorano NF, Saint-Mezard V and Teguo MTVillalba NL, Merzouki T, González NS, Ortiz MBA, Kechida M, Bailon MM, Zamorano NF, Saint-Mezard V and Teguo MT
  
  We are reporting the case of a 61 year old male patient with a medical history of pancreatic cancer on chemotherapy presenting a uremic hemolytic syndrome after the administration of gemcitabine. The renal function progressively worsened during his stay in spite of general measures and steroids, leading to the death at day 12 of admission... Read More»
  DOI: 10.4172/2165-7831.1000168

  Abstract PDF